1H NMR evidence that Glu-38 interacts with the N-terminal functional domain in interleukin-8  by Rajarathnam, Krishnakumar et al.
FEBS 17883 FEBS Letters 399 (1996) 4346 
lH NMR evidence that Glu-38 interacts with the N-terminal functional 
domain in interleukin-8 
Krishnakumar Rajarathnam”, Ian Clark-Lewisb, Beatrice Dewald”, Marco Baggiolini”, 
Brian D. Sykes”>* 
BProtein Engineering Network of Centres of Excellence (PENCE) and the Department of Biochemistry, University of Alberta, Edmonton, 
Alberta T6G 2S2, Canada 
bPENCE, the Biomedical Research Centre, the Department of Biochemistry and Molecular Biology, University of British Columbia, 
Vancouver, BC V6T 123 Canada 
“Theodor-Kocher Institute. University of Bern, P.O. Box 99, CH-3000 Bern, Switzerland 
Received 23 August 1996; revised version received 18 October 1996 
Abstract In order to assess the importance of the buried Glu-38 
observed in the structure of interleukin-8, an analog in which 
Glu-38 was replaced with Ala (E38A analog) was investigated by 
‘H NMR spectroscopy and neutrophil activation. Detailed 
analysis of the NMR NOESY data showed that the solution 
structure of the E38A analog is essentially the same as that for 
the native protein. Also, the neutrophil elastase activity of the 
E38A analog was similar to that of the native protein. However, 
the Gln-8 and Cys-9 amide proton chemical shifts, which are 
significantly downfield-shifted in the native protein, exhibit more 
‘normal’ values. This observation indicates that in the native 
protein, Glu-38 side-chain carboxylate interacts with Gln-8 and 
Cys-9 amide protons. Although the N-terminal residues are 
critical for function, this interaction is not essential for neutrophil 
activation. 
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1. Introduction 
Interleukin-8 (IL-g) belongs to a family of proteins called 
chemokines (chemoattractant cytokines) that are actively in- 
volved in recruitment of leukocytes to sites of inflammation 
[1,2]. They have four conserved cysteines and are classified 
into CXC chemokines or CC chemokines on the basis of 
whether the first two cysteines are separated by one amino 
acid (C-X-C) or are adjacent (C-C). The two subfamilies 
are also functionally distinct: whereas the CXC chemokines 
activate neutrophils, CC chemokines activate monocytes, lym- 
phocytes and eosinophils. IL-8 remains the best characterized 
chemokine and its structure-function relationship has been 
the focus of a number of studies [3-91. 
The structure of IL-8, determined by NMR and X-ray 
methods, showed it to be a homodimer [lO,ll]. A monomeric 
IL-8 analog was shown to be fully active, suggesting that 
dimerization is not essential for functional activation [7]. 
The monomer consists of a series of turns in the N-terminus 
followed by three p strands and a C-terminal a-helix. The 
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four cysteines are involved in disulfide bond formation (Cys- 
7 and Cys-34; Cys-9 and Cys-50) and have been shown to be 
essential for tertiary structure and function. Functional stud- 
ies have shown that the most critical residues for activity are 
the flexible N-terminal residues Glu-4, Leu-5, Arg-6 (‘ELR’ 
motif) [3,5]. In addition, residues 31-34, which form a contig- 
uous surface with the ‘ELR’ motif, and residues 10-22, which 
are also solvent exposed, were also shown to be essential [4]. 
Structural studies of a number of analogs combined with the 
above findings suggest that the core of the protein acts as a 
scaffold from which the ‘ELR’ motif and the other surface 
residues are suspended in a way which facilitates receptor 
binding and neutrophil activation [6]. 
Glu-38 is highly conserved among all human and other 
mammalian CXC chemokines (Fig. 1). The NMR and X- 
ray structures of native dimeric IL-8 [lO,ll], NMR structure 
of an active monomeric IL-8 [12], two solution structures of 
MGSA [13,14], and X-ray structure of PF-4 [IS] are known to 
date. In all of the structures, Glu-38 (Gln in PF-4) was ob- 
served to be buried and pointed in a direction towards the N- 
terminal residues (Fig. 2). In both IL-8 and MGSA NMR 
structures, Gln-8 amide proton was significantly downfield- 
shifted, indicating that they are involved in an H-bonding 
interaction and we suspected that the interaction could in- 
volve the Glu-38 carboxylate side chain. Buried charged resi- 
dues are unusual and if present are generally stabilized by 
electrostatic or H-bonding interactions [16]. We were inter- 
ested in finding out if Glu-38 in IL-8 is involved in such an 
interaction and also whether this interaction plays a func- 
tional role. In order to address these questions, we substituted 
Glu-38 + Ala (E38A) and have studied this analog by NMR 
methods and have addressed the functional response by assay- 
ing elastase release from the neutrophils. 
2. Materials and methods 
IL-8 E38A analog was chemically synthesized, purified and charac- 
terized as described previously [17]. The elastase release activity was 
determined with freshly isolated neutrophils as described previously 
[181. 
‘H NMR spectra were acquired on a Varian Unity 600 spectrom- 
eter at 30°C and 40°C as discussed in detail previously [12]. The 
protein concentration was N 2 mM in 20 mM sodium acetate aqueous 
buffer, pH 5.2. The NOESY (150 ms) [19], TOCSY (55 ms) [20] and 
DQF-COSY [21] were collected for resonance assignments and quad- 
rature detection along the tl dimension was achieved using the States 
method [22]. The solvent was suppressed using presaturation and for 
NOESY and DQF-COSY experiments, the loss of intensity of the 
cross peaks near Hz0 signal was minimized using the SCUBA se- 
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quence [23]. All spectra were referenced to the internal DSS at 0.00 
ppm. 
3. Results and discussion 
Assignment of the chemical shifts of the E38A analog was 
accomplished using standard 2-dimensional NMR methods. 
Scalar connectivities were identified from the TOCSY and 
DQF-COSY spectra and through space connectivities were 
identified from the NOESY spectra. The assignments were 
fairly straight forward as the chemical shifts of most of the 
protons were similar to the native protein. The downfield 
region of the l-dimensional spectra in Hz0 of the native 
and the E38A analog is shown in Fig. 3. The two down- 
field-shifted signals were previously assigned to Gln-8 and 
Lys-20 amide protons in the native protein and it is seen 
that the peak from Gln-8 is missing in the E38A analog in- 
dicating it has shifted more upfield. Chemical shifts of the 
CaH protons are sensitive to secondary and tertiary structure, 
whereas the chemical shifts of the amide protons in addition 
to the secondary and tertiary structure, are also sensitive to 
parameters such as H-bonding and exchange with the bulk 
solvent [24]. The differences in the chemical shifts of the amide 
and the CaH protons between the native and the E38A analog 
are shown in Fig. 4. Chemical shifts of the CaH protons are 
essentially similar between the two proteins except for small 
differences (N 0.1 ppm) at the site of substitution and for 
residues at the N-terminus, suggesting that the structures are 
largely similar. However, in the case of amide protons, very 
large chemical shift differences between the two proteins are 
seen for Gln-8 (N 3 ppm) and Cys-9 (N 1 ppm). Detailed 
analysis of the NOESY data indicated that the tertiary struc- 
ture of the two proteins are largely similar. Hence, the chem- 
ical shift differences of the Gln-8 and Cys-9 amide protons can 
be directly attributed to the Glu+Ala substitution and that 
the Gln-8 and Cys-9 amide protons are involved in an H- 
bonding interaction with Glu-38 carboxylate oxygens in the 
native protein. 
On the basis of the native NMR structure, the downfield 
shift of Gln-8 was attributed to H-bonding with the His-33 
side chain NE2 [lo]. However, we had shown earlier that in the 
H33A analog, Gln-8 and Cys-9 have similar chemical shifts as 
the native protein [6]. In the X-ray structure, both the carbox- 
ylate oxygens of Glu-38 are optimally oriented for H-bonding 
to the Gln-8 and Cys-9 amide protons [ll]. In the native 
NMR [lo] and in the monomeric NMR structures [12], Glu- 
38 was found to be disordered but nevertheless buried and 
oriented towards the N-terminal region. The present NMR 
data of the E38A analog provide evidence that Glu-38 side- 
Sequences of human and other mammalian a-chemokines 
Fig. 1. A comparison of the amino acid sequences of the N-terminal 
region of human and other mammalian cc-chemokines. 
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Fig. 2. Schematic presentation of the N-terminal region and the or- 
ientation of Glu-38 side chain in the IL-8 structure. 
chain carboxylate interacts with Gln-8 backbone amide pro- 
ton. The large change in chemical shift (> 3 ppm) also sug- 
gests that that Glu-38 adopts a unique conformation similar 
to what is seen in the X-ray structure and it is likely that the 
side-chain orientation in the NMR structures were not fixed 
due to lack of distance and/or dihedral constraints. 
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Fig. 3. Downfield region of the 600 MHz ‘H NMR spectra at 40°C 
of the (A) native IL-8 and (B) E38A analog. 
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Similar substantial downfield shifts for the Gln-9’ (N 11.2 
ppm) and moderate downfield shifts for the Cys-10’ (-9.5 
ppm) amide protons are observed in MGSA [13,14] and the 
rat CINClGro [25] suggesting that H-bonding interaction ex- 
ists between Gln-9, Cys-10 amide protons and Glu-39l side- 
chain carboxylate in these proteins. This was confirmed to be 
the case as the Gln-9 amide shift was upfield-shifted in a 
MGSA mutant in which Glu-39 was substituted with Ala. 
Glu-39 was found to be disordered but oriented towards the 
N-terminal domain in the MGSA NMR structures [13,14] but 
the chemical shifts of the Gln-9 and Cys-10 amide protons 
suggest that Glu-39 adopts a unique conformation in 
MGSA structure. 
Two receptors (IL-8Rl and IL-8R2) have been identified 
for neutrophils, of which IL-8R2 (also called B-type) binds 
IL-8 NAP-2 and MGSA with equal affinity and the IL-8Rl 
(also called A-type) binds IL-8 with high affinity and NAP-2 
and MGSA with low affinity [26-281. The Duffy antigen re- 
ceptor for chemokines (DARC) is less specific and binds 
members of both CXC and CC chemokines with medium 
affinity [29,30]. The activity of the E38A analog was assessed 
by measuring the elastase release from neutrophils (Fig. 5). It 
was observed that the activity is essentially the same as that 
seen for the native protein, suggesting that the loss of the H- 
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Fig. 5. Neutrophil elastase release activity of native IL-8 (0) and 
E38A mutant (0). Data are representative of three assays using dif- 
ferent neutrophil preparations. 
bonding interaction between Glu-38 and the functionally im- 
portant N-terminal residues Gln-8 and Cys-9 is not critical for 
receptor binding. Interestingly, mutation of Glu-39 to Ala in 
MGSA showed a 9-fold reduction in binding to neutrophils 
(data not shown). The data for the MGSA mutant is consist- 
ent with a previous study which showed a 12-fold reduction 
for IL-8R2 receptor and neutrophil activity and a 64-fold 
reduction in binding to the DARC receptor [31]. This obser- 
vation suggests that this H-bonding interaction plays a role in 
MGSA for maximal interaction with the receptor. 
It is believed that buried charged residues which are con- 
served play a structural and/or a functional role [16]. In the 
case of IL-8, it retains substantial secondary structure in 9M 
urea and at temperature of 85°C indicating that it is largely 
stabilized by the two disulfide bonds and the hydrophobic 
core. Hence it is unlikely that the H-bonding interaction be- 
tween the Glu-38 and Gln-8 is critical for structural stability. 
Indeed, thermal denaturation of the E38A analog showed a 
similar profile as observed for the native protein. The func- 
tional data suggets that this H-bonding interaction plays a 
differential role between IL-8 and MGSA. We speculate that 
in IL-8, this interaction is completely unrelated to activation 
of the IL-8 receptor, but may play a role in other events, such 
as an aspect of 11-8 function that we have not yet examined or 
in the initiation and kinetics of protein folding. 
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Fig. 4. A plot of the difference in chemical shifts between IL-8 (4 
72) and the E38A (472) substitution analog for the (A) amide and 
(B) CaH protons. A positive difference implies a larger chemical 
shift in the native protein. Both proteins were synthesized in the 4 
72 version as the IL-8 (4-72) analog was shown to be as potent as 
the native (l-72) analog in receptor binding and functional activa- 
tion [4]. 
‘The residues Gln-9, Cys-10 and Glu-39 in MGSA and rat CINCl 
Gro correspond to residues Gln-8, Cys-9 and Glu-38 in interleukin- 
8 (Fig. 1). 
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